<?xml version="1.1" encoding="UTF-8" standalone="yes"?><xml><head><creation_date>D:20020925102022Z</creation_date><modification_date>D:20060321221244+01'00'</modification_date><initial_authorization>False</initial_authorization><pdf_file>EU-1-00-168_h_w_dec_2.pdf</pdf_file></head><body><section><header>en</header><p>commission of the european communitiesbrussels, 18/09/2002c(2002) 3551
 not for publication</p></section><section><header>commission decisionof 18/09/2002
 amending decision c(2001)286 on the marketing authorization for
 the medicinal product for human use
 &quot;tenecteplase boehringer ingelheim pharma kg - tenecteplase&quot;
  (text with eea relevance)</header><p>only the german text is authentic.</p></section><section><header>commission decisionof 18/09/2002
 amending decision c(2001)286 on the marketing authorization for
 the medicinal product for human use
 &quot;tenecteplase boehringer ingelheim pharma kg - tenecteplase&quot;
  (text with eea relevance)</header><p>the commission of the european communities,having regard to the treaty establishing the european community,
 having regard to council regulation (eec) no 2309/93 of 22 july 1993 laying down
 community procedures for the authorization and supervision of medicinal products for
 human and veterinary use and establishing a european agency for the evaluation of
 medicinal products
 1, as amended by commission regulation (ec) no 649/982,having regard to commission regulation (ec) no 542/95 of 10 march 1995 concerning
 the examination of variations to the terms of a marketing authorisation falling within the
 scope of council regulation (eec) no 2309/93
 3, as amended by commissionregulation (ec) no 1069/98
 4, and in particular article 8(3) thereof,having regard to the opinion of the european agency for the evaluation of medicinal
 products,
 whereas:
 (1)</p><p>the medicinal product &quot;tenecteplase boehringer ingelheim pharma kg -
 tenecteplase&quot; entered in the community register of medicinal products under nos
 eu/1/00/168/001-003 authorised by commission decision c(2001)286 of 23
 february 2001, as amended, complies with the requirements set out in regulation
 (eec) no 2309/93.
 (2)</p><p>boehringer ingelheim international gmbh submitted an application on 22
 february 2002 pursuant to article 6(1) set out in regulation (ec) no 542/95.
 (3)</p><p>the european agency for the evaluation of medicinal products delivered a
 favourable opinion formulated on 30 may 2002 by the committee for proprietary
 medicinal products,</p><p> 
 1 oj no l 214, 24. 8. 1993, p. 1.2 oj l 88, 24.3.1998, p. 7.3 oj no l 55, 11.3.1995, p. 154 oj l 153, 27.5.1998, p. 11(4) decision c(2001)286 should therefore be amended accordingly.
 has adopted this decision:
 article 11. the following numbers are added to article 1 and entered in the community registerof medicinal products.
 eu/1/00/168/004
 tenecteplase boehringer ingelheim pharma kg-6,000 units (30
 mg)-powder and solvent for solution for injection -intravenous use-
 powder: vial (glass) solvent: pre-filled syringe (cycloolefine-
 copolymen)-6000 units (30 mg)/ml 6 ml (1000 u/ml-5 mg/ml)-1 vial
 + 1 syringe
 eu/1/00/168/005
 tenecteplase boehringer ingelheim pharma kg-8,000 units (40
 mg)-powder and solvent for solution for injection -intravenous use-
 powder: vial (glass) solvent: pre-filled syringe (cycloolefine-
 copolymen)-8000 units (40 mg)/ml 8 ml (1000 u/ml-5 mg/ml)-1 vial
 +1 syringe
 eu/1/00/168/006
 tenecteplase boehringer ingelheim pharma kg-10,000 units (50
 mg)-powder and solvent for solution for injection -intravenous use-
 powder: vial (glass) solvent: pre-filled syringe (cycloolefine-
 copolymen)-10000 units (50 mg)/ml 10 ml (1000 u/ml-5 mg/ml)-1
 vial +1 syringe
 2. annex i is replaced by annex i to this decision;3. annex iii a is replaced by annex ii to this decision.article 2this decision is addressed to boehringer ingelheim international gmbh, binger strasse173, d-55216 ingelheim am rhein, deutschland.
 done at brussels, 18/09/2002
 for the commissionerkki liikanen
 member of the commission</p></section></body></xml>